Divis Gregory J — SEC insider filings

SEC reporting owner CIK 1410677. 15 insider filings on record with FilingPulse; latest filed 2026-11-12.

Transaction summary — filings shown

Covers all 15 filings on record, filed 2020-08-13 to 2026-11-12. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
AVADEL PHARMACEUTICALS PLC (AVDL)Chief Executive Officer, Director105 legs · 83,000 sh · $435,359—18
Jaguar Health, Inc. (JAGX)Director3——5
InMed Pharmaceuticals Inc. (MTRI)See Remarks, Director2——1

Insider filings — Divis Gregory J

FiledFormIssuerReported transactionsSource
2026-11-123InMed Pharmaceuticals Inc. (MTRI)Holdings only — no transactions reportedEDGAR
2026-11-124InMed Pharmaceuticals Inc. (MTRI)Grant/award (A): 1,560,599 (derivative) @ $0EDGAR
2026-02-124AVADEL PHARMACEUTICALS PLC (AVDL)Disposition to issuer (D): 211,105 @ $21 · Disposition to issuer (D): 10,000 @ $21 · Disposition to issuer (D): 150,000 (derivative) · Disposition to issuer (D): 100,000 (derivative) · Disposition to issuer (D): 50,000 (derivative) · Disposition to issuer (D): 100,000 (derivative) · +6 moreEDGAR
2025-03-074AVADEL PHARMACEUTICALS PLC (AVDL)Grant/award (A): 52,000 @ $0 · Grant/award (A): 310,000 (derivative) @ $0EDGAR
2024-12-104AVADEL PHARMACEUTICALS PLC (AVDL)Purchase (P): 9,598 @ $9.98 · Purchase (P): 402 @ $9.82EDGAR
2024-03-044AVADEL PHARMACEUTICALS PLC (AVDL)Grant/award (A): 600,000 (derivative) @ $0EDGAR
2023-08-104AVADEL PHARMACEUTICALS PLC (AVDL)Purchase (P): 10,000 @ $13.20EDGAR
2023-06-054AVADEL PHARMACEUTICALS PLC (AVDL)Grant/award (A): 350,000 (derivative) @ $0EDGAR
2022-05-314AVADEL PHARMACEUTICALS PLC (AVDL)Purchase (P): 50,000 @ $2.05EDGAR
2022-05-184Jaguar Health, Inc. (JAGX)Option exercise (M): 12,133 · Option exercise (M): 12,133 (derivative) @ $0EDGAR
2022-03-304Jaguar Health, Inc. (JAGX)Grant/award (A): 85,900 (derivative) @ $0EDGAR
2021-12-094AVADEL PHARMACEUTICALS PLC (AVDL)Grant/award (A): 310,000 (derivative) @ $0EDGAR
2021-05-204Jaguar Health, Inc. (JAGX)Grant/award (A): 72,750 (derivative) @ $0 · Grant/award (A): 36,400 (derivative) @ $0EDGAR
2020-12-094AVADEL PHARMACEUTICALS PLC (AVDL)Grant/award (A): 500,000 (derivative) @ $0EDGAR
2020-08-134AVADEL PHARMACEUTICALS PLC (AVDL)Purchase (P): 13,000 @ $7.78EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-08-10 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1410677 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs